Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.2% |
| EBIT Margin |
15.5% |
| EBITDA Margin |
28.8% |
| Operating Margin |
32.8% |
| Pretax Margin |
10.8% |
| Cont. Ops Margin |
6.9% |
| Net Margin |
6.9% |
| Bottom Line Margin |
6.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.67 |
| Quick Ratio |
0.56 |
| Solvency Ratio |
0.090 |
| Cash Ratio |
0.12 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-77.01 |
| Forward PEG |
-77.01 |
| Price/Book |
-124.40 |
| Price/Sales |
6.65 |
| Price/FCF |
22.83 |
| Price/Op Cash Flow |
21.38 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5156 |
| Debt/Equity |
-21.1217 |
| Debt/Capital |
1.0497 |
| Long-Term Debt/Capital |
1.0580 |
| Financial Leverage |
-40.97 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-4.47 |
| Operating Cash Flow Ratio |
0.440 |
| Operating Cash Flow/Sales |
31.1% |
| Free Cash Flow/Operating Cash Flow |
93.6% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.31 |
| Interest Coverage |
6.9447 |
| Short-Term Operating Cash Flow Coverage |
2.18 |
| Operating Cash Flow Coverage |
0.28 |
| Capital Expenditure Coverage |
15.68 |
| Dividend + Capital Expenditure Coverage |
1.48 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
275.8400% |
| Dividend Yield |
2.8655% |
| Dividend Yield % |
2.8655% |
| Dividend Per Share |
6.5474 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
34.35 |
| EPS |
2.374 |
| Debt/Share |
40.4186 |
| Cash/Share |
2.95 |
| Book Value/Share |
-1.81 |
| Tangible BV/Share |
-51.40 |
| Equity/Share |
-1.84 |
| Operating Cash Flow/Share |
10.689 |
| Capital Expenditure/Share |
0.682 |
| FCF/Share |
10.007 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.641 |
| Earnings Before Tax/EBIT |
0.328 |
| Price/Fair Value |
-124.40 |
| Debt/Market Cap |
0.1680 |
| Effective Tax Rate |
35.8% |
| Enterprise Value Multiple |
26.70 |
ABBV - AbbVie Inc.